XML 26 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Option Plans (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total unrecognized compensation costs $ 5,609,851    
Weighted average recognition period 5 years 5 months 23 days    
Weighted-average estimated fair value of stock options granted (in dollars per share) $ 4.13 $ 4.13  
Weighted-average assumptions [Abstract]      
Expected life (in years) 6 years 8 months 5 days 6 years 4 months 6 days  
Risk-free interest rates (in hundredths) 1.51% 1.06%  
Volatility (in hundredths) 95.22% 98.88%  
Dividend yield (in hundredths) 0.00% 0.00%  
Number of Options Outstanding [Rollforward]      
Exercised (in shares)   (98,541)  
Weighted Average Exercise Price [Rollforward]      
Exercised (in dollars per share)   $ 2.91  
$0.50 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 0.50    
Number Outstanding (in shares) 1,970,400    
Options Outstanding, Weighted Avg. Remaining Contractual Life 0 years 9 months 7 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 0.50    
Number Exercisable (in shares) 1,970,400    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 0.50    
2.30-8.58 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Number Outstanding (in shares) 2,596,735    
Options Outstanding, Weighted Avg. Remaining Contractual Life 4 years 10 months 10 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 4.39    
Number Exercisable (in shares) 1,277,262    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 4.54    
2.30-8.58 [Member] | Minimum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 2.30    
2.30-8.58 [Member] | Maximum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 8.58    
$0.50-$8.58 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Number Outstanding (in shares) 4,567,135    
Options Outstanding, Weighted Avg. Remaining Contractual Life 3 years 1 month 6 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 2.71    
Number Exercisable (in shares) 3,247,662    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 2.09    
$0.50-$8.58 [Member] | Minimum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 0.50    
$0.50-$8.58 [Member] | Maximum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 8.58    
0.003-$0.75 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Number Outstanding (in shares) 5,256,226    
Options Outstanding, Weighted Avg. Remaining Contractual Life 5 years 11 months 16 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 0.36    
Number Exercisable (in shares) 4,089,035    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 0.35    
0.003-$0.75 [Member] | Minimum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 0.003    
0.003-$0.75 [Member] | Maximum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 0.75    
1.00-1.75 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Number Outstanding (in shares) 2,072,342    
Options Outstanding, Weighted Avg. Remaining Contractual Life 5 years 10 months 10 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 1.57    
Number Exercisable (in shares) 571,073    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 1.43    
1.00-1.75 [Member] | Minimum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 1.00    
1.00-1.75 [Member] | Maximum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 1.75    
2.05 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 2.05    
Number Outstanding (in shares) 4,080,000    
Options Outstanding, Weighted Avg. Remaining Contractual Life 6 years 4 months 20 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 2.25    
Number Exercisable (in shares) 1,294,062    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 2.16    
27.00-42.02 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Number Outstanding (in shares) 7,840    
Options Outstanding, Weighted Avg. Remaining Contractual Life 6 years 9 months 18 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 37.35    
Number Exercisable (in shares) 7,840    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 37.35    
27.00-42.02 [Member] | Minimum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 27.00    
27.00-42.02 [Member] | Maximum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 42.02    
0.003-$42.02 [Member]
     
Additional Information regarding options outstanding [Abstract]      
Number Outstanding (in shares) 11,416,408    
Options Outstanding, Weighted Avg. Remaining Contractual Life 6 years 1 month 6 days    
Options Outstanding, Weighted Average Exercise Price (in dollars per share) $ 1.28    
Number Exercisable (in shares) 5,962,010    
Options Exercisable, Weighted Average Exercise Price (in dollars per share) $ 0.89    
0.003-$42.02 [Member] | Minimum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 0.003    
0.003-$42.02 [Member] | Maximum [Member]
     
Additional Information regarding options outstanding [Abstract]      
Range of Exercise Prices, Upper Range Limit (in dollars per share) $ 42.02    
2002 Plan and 2012 Plan [Member]
     
Options Available for Grant [Rollforward]      
Beginning of the period (in shares) 3,745,000 1,303,193 1,842,168
Granted (in shares) (1,585,000)    
Exercised (in shares) 0 0 0
Forfeited/expired (in shares)     21,468
End of the period (in shares) 2,315,000 3,745,000 1,303,193
Number of Options Outstanding [Rollforward]      
Outstanding, beginning of the period (in shares) 3,681,301 3,408,905 3,320,590
Granted (in shares) 1,585,000    
Exercised (in shares) (20,000) (98,541) (450,660)
Forfeited/expired (in shares)     (21,468)
Outstanding, end of the period (in shares) 4,567,135 3,681,301 3,408,905
Weighted Average Exercise Price [Rollforward]      
Outstanding, beginning of the period (in dollars per share) $ 1.96 $ 2.18 $ 1.13
Granted (in dollars per share) $ 4.13    
Exercised (in dollars per share) $ 2.30 $ 2.91 $ 0.50
Forfeited/expired (in dollars per share)     $ 5.60
Outstanding end of the period (in dollars per share) $ 2.71 $ 1.96 $ 2.18
2002 Plan [Member]
     
Options Available for Grant [Rollforward]      
Granted (in shares)   (280,000) (560,443)
Forfeited/expired (in shares) 0 0  
Reduce options ungranted under 2002 Plan (in shares)   (1,023,193) [1]  
Number of Options Outstanding [Rollforward]      
Granted (in shares)   280,000 560,443
Forfeited/expired (in shares) (524,166) (164,063)  
Reduce options ungranted under 2002 Plan (in shares)   0 [1]  
Weighted Average Exercise Price [Rollforward]      
Granted (in dollars per share)   $ 4.75 $ 4.89
Forfeited/expired (in dollars per share) $ 4.01 $ 5.60  
Reduce options ungranted under 2002 Plan (in dollars per share)   $ 0 [1]  
2012 Plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common shares reserved for future issuance (in shares) 4,000,000    
Period when options may not be granted or exercised 10 years    
Options Available for Grant [Rollforward]      
Granted (in shares)   (255,000)  
Forfeited/expired (in shares) 155,000    
Added by 2012 Plan (in shares)   4,000,000 [2]  
Number of Options Outstanding [Rollforward]      
Granted (in shares)   255,000  
Forfeited/expired (in shares) (155,000)    
Added by 2012 Plan (in shares)   0 [2]  
Weighted Average Exercise Price [Rollforward]      
Granted (in dollars per share)   $ 3.45  
Forfeited/expired (in dollars per share) $ 4.18    
Added by 2012 Plan (in dollars per share)   $ 0 [2]  
OncoCyte, OrthoCyte and ReCyte Therapeutics stock option plans [Member]
     
Additional Information regarding options outstanding [Abstract]      
Authorize number of shares under stock option plan (in shares)     4,000,000
BioTime Asia stock option plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options to purchase for employees (in shares) 4,500,000    
Additional Information regarding options outstanding [Abstract]      
Authorize number of shares under stock option plan (in shares) 14,100    
Cell Cure Neurosciences' option plan [Member]
     
Additional Information regarding options outstanding [Abstract]      
Authorize number of shares under stock option plan (in shares) 1,600    
Granted under 2012 Plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options to purchase for employees (in shares) 4,000,000    
Lifemap Stock Option Plan [Member]
     
Additional Information regarding options outstanding [Abstract]      
Authorize number of shares under stock option plan (in shares)   8,000,000  
Asterias Equity Incentive Plan [Member]
     
Number of Options Outstanding [Rollforward]      
Granted (in shares) 50,000    
[1] During September 2012, the 2002 Plan expired.
[2] During December 2012, the 2012 Equity Incentive Plan was approved by the BioTime Board of Directors making 4,000,000 common shares available for the grant of options. This plan was approved by the shareholders during October 2013.